SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-024242
Filing Date
2020-05-11
Accepted
2020-05-11 16:27:19
Documents
13
Period of Report
2020-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stro-8k_20200511.htm   iXBRL 8-K 35809
2 EX-99.1 stro-ex991_6.htm EX-99.1 175493
  Complete submission text file 0001564590-20-024242.txt   360501

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA stro-20200511.xsd EX-101.SCH 5776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20200511_lab.xml EX-101.LAB 20225
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20200511_pre.xml EX-101.PRE 12086
7 EXTRACTED XBRL INSTANCE DOCUMENT stro-8k_20200511_htm.xml XML 3681
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 20865233
SIC: 2836 Biological Products, (No Diagnostic Substances)